font size: |
 |
 |
|
 |
 |
| |
|

 
ProNAi Therapeutics, Inc. is a privately held biopharmaceutical company. To date, the company has raised $15 million in equity and convertible notes.
ProNAi’s major investors include:
- Grand Angels, Grand Rapids, MI
- Biosciences Research Commercialization Center, Kalamazoo, MI
- Apjohn Ventures, Kalamazoo, MI
- Michigan Technology Tri-Corridor, Lansing, MI
- Sigvion Ventures, Chicago, IL
- 21st Century Jobs Fund, Lansing, MI
- Amherst Fund, Ann Arbor, MI
|
|
|
| |
|